Patent Assignment
Reel/Frame 024056/0082
Assignment of Assignor's Interest
Recorded: 2010-03-10
Pages: 8
Assignors
FRUEHAUF, JOHANNES HEINRICH
Executed: 2010-02-10
VAZE, MORESWHAR BHANUDAS
Executed: 2009-12-15
LAROUX, FLOYD STEPHEN
Executed: 2009-12-18
SEXTON, JESSICA ANN
Executed: 2010-01-04
Assignee
CEQUENT PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, BUILDING 700, 1ST FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
E. Coli Mediated Gene Silencing of Beta-Catenin
Application:
12/618,401 →
Publication:
US 2010/0189691
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →
Security Interest
Nov 23, 2021
From: ADHERA THERAPEUTICS, INC.
To: CAVALRY FUND I LP
Reel/Frame 058312/0195 →